Clinical Trials for Heidelberg Pharma

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Heidelberg Pharma

Clinical Trials (1)

NCT04879043
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
78 participants
Started: Feb 7, 2022 · Completed: May 31, 2026
2 conditions1 sponsor16 locations